Portfolio Holdings Detail for ISIN IE000D3BWBR2
Stock Name / FundiShares S&P 500 Swap UCITS ETF USD (Dist)
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity Type
Entity LEI 549300VML6THE3JJOS76
ETF TickerI50D(USD) Euronext Amsterdam

Holdings detail for REGN

Stock NameRegeneron Pharmaceuticals Inc
TickerREGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS75886F1075
LEI549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL
Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors
Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN
In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC
Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.
Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.
D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares S&P 500 Swap UCITS ETF USD (Dist) REGN holdings

DateNumber of REGN Shares HeldBase Market Value of REGN SharesLocal Market Value of REGN SharesChange in REGN Shares HeldChange in REGN Base ValueCurrent Price per REGN Share HeldPrevious Price per REGN Share Held
2025-11-17 (Monday)-12,531REGN holding increased by 25062USD -8,825,709REGN holding increased by 17515958USD -8,825,70925,062USD 17,515,958 USD 704.31 USD 0
2025-11-17 (Monday)12,531REGN holding increased by 25062USD 8,825,709REGN holding increased by 17515958USD 8,825,70925,062USD 17,515,958 USD 704.31 USD 0
2025-11-14 (Friday)-12,531REGN holding increased by 25062USD -8,690,249REGN holding increased by 17399169USD -8,690,24925,062USD 17,399,169 USD 693.5 USD 0
2025-11-14 (Friday)12,531REGN holding increased by 25062USD 8,690,249REGN holding increased by 17399169USD 8,690,24925,062USD 17,399,169 USD 693.5 USD 0
2025-11-13 (Thursday)-12,531REGN holding increased by 25062USD -8,708,920REGN holding increased by 17251553USD -8,708,92025,062USD 17,251,553 USD 694.99 USD 0
2025-11-13 (Thursday)12,531REGN holding increased by 25062USD 8,708,920REGN holding increased by 17251553USD 8,708,92025,062USD 17,251,553 USD 694.99 USD 0
2025-11-12 (Wednesday)-12,531REGN holding increased by 47899USD -8,542,633REGN holding increased by 32400117USD -8,542,63347,899USD 32,400,117 USD 681.72 USD 0
2025-11-12 (Wednesday)12,531REGN holding increased by 47899USD 8,542,633REGN holding increased by 32400117USD 8,542,63347,899USD 32,400,117 USD 681.72 USD 0
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE000D3BWBR2

Show aggregate share trades of REGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-17BUY25,062711.880692.290 694.249USD 17,399,268 623.45
2025-11-14BUY25,062699.270686.000 687.327USD 17,225,789 623.15
2025-11-13BUY25,062713.580679.930 683.295USD 17,124,739 622.84
2025-11-12BUY47,899 681.720* 622.58
2025-11-11BUY70,736676.330651.410 653.902USD 46,254,410 622.35
2025-11-10BUY70,736665.990653.190 654.470USD 46,294,590 622.21
2025-11-07BUY70,736 657.530* 622.05
2025-11-06BUY70,736657.000641.260 642.834USD 45,471,506 621.94
2025-11-05BUY70,736646.895628.000 629.890USD 44,555,871 621.84
2025-11-04BUY70,736646.221625.140 627.248USD 44,369,025 621.82
2025-11-03BUY70,736657.460627.500 630.496USD 44,598,765 621.72
2025-10-31BUY70,736659.760645.000 646.476USD 45,729,126 621.59
2025-10-30BUY70,736664.000645.000 646.900USD 45,759,118 621.44
2025-10-29BUY47,899652.910659.980 659.273USD 31,578,516 621.30
2025-10-28BUY25,062654.480655.700 655.578USD 16,430,096 621.14
2025-10-27BUY25,062585.310586.150 586.066USD 14,687,987 621.31
2025-10-24BUY25,062577.950582.700 582.225USD 14,591,723 621.51
2025-10-23BUY25,062575.690584.000 583.169USD 14,615,381 621.72
2025-10-22BUY25,062584.740588.710 588.313USD 14,744,301 621.90
2025-10-21BUY25,062579.340582.410 582.103USD 14,588,665 622.10
2025-10-20BUY25,062576.770582.650 582.062USD 14,587,638 622.31
2025-10-17BUY25,062578.050579.040 578.941USD 14,509,419 622.52
2025-10-16BUY25,062569.170589.080 587.089USD 14,713,625 622.77
2025-10-15BUY25,062576.420584.870 584.025USD 14,636,834 623.00
2025-10-14BUY25,062572.600576.180 575.822USD 14,431,251 623.24
2025-10-13SELL-25,062557.730563.770 563.166USD -14,114,067 625.50 Profit of 1,562,196 on sale
2025-10-08BUY25,062563.860605.000 600.886USD 15,059,405 625.80
2025-10-07BUY25,062583.240591.450 590.629USD 14,802,344 626.01
2025-10-06BUY25,062585.480603.650 601.833USD 15,083,139 626.20
2025-10-03BUY25,062600.000618.010 616.209USD 15,443,430 626.33
2025-10-02BUY25,062600.000605.410 604.869USD 15,159,226 626.46
2025-10-01BUY25,062599.940615.390 613.845USD 15,384,184 626.60
2025-09-30BUY26,730562.270574.040 572.863USD 15,312,628 626.92
2025-09-29BUY28,398560.750564.910 564.494USD 16,030,500 627.25
2025-09-26BUY28,398563.900564.610 564.539USD 16,031,778 627.57
2025-09-25BUY28,398555.510579.000 576.651USD 16,375,735 627.94
2025-09-24SELL-28,398576.980577.980 577.880USD -16,410,636 630.38 Profit of 1,490,817 on sale
2025-09-18BUY43,316598.710600.000 599.871USD 25,984,012 630.54
2025-09-17BUY43,316585.500587.670 587.453USD 25,446,113 630.77
2025-09-16BUY43,316575.060579.400 578.966USD 25,078,492 631.06
2025-09-15SELL-43,316572.590573.690 573.580USD -24,845,191 633.59 Profit of 2,599,235 on sale
2025-09-12BUY43,316560.000570.000 569.000USD 24,646,804 633.97
2025-09-11BUY43,316568.200570.760 570.504USD 24,711,952 634.32
2025-09-10BUY43,316555.830560.000 559.583USD 24,238,897 634.73
2025-09-09BUY43,316556.530563.570 562.866USD 24,381,104 635.15
2025-09-08BUY43,316558.440571.200 569.924USD 24,686,828 635.56
2025-09-05BUY43,316573.380577.750 577.313USD 25,006,890 635.89
2025-09-04SELL-43,316567.220581.980 580.504USD -25,145,110 638.52 Profit of 2,513,200 on sale
2025-09-02BUY30,785577.900585.490 584.731USD 18,000,944 638.85
2025-08-29BUY18,254580.700581.250 581.195USD 10,609,134 639.17
2025-08-28BUY18,254579.610590.960 589.825USD 10,766,666 639.50
2025-08-27SELL-18,254586.960597.020 596.014USD -10,879,640 642.06 Profit of 840,434 on sale
2025-08-12BUY51,147556.550562.740 562.121USD 28,750,802 642.53
2025-08-11BUY88,868545.940572.580 569.916USD 50,647,296 643.07
2025-08-08BUY88,868563.000567.690 567.221USD 50,407,796 643.52
2025-08-07BUY88,868559.800565.480 564.912USD 50,202,598 643.99
2025-08-06BUY88,868555.130573.470 571.636USD 50,800,146 644.50
2025-08-05BUY88,868569.900579.820 578.828USD 51,439,288 644.92
2025-08-04BUY88,868571.540577.210 576.643USD 51,245,112 645.35
2025-08-01BUY88,868558.870583.280 580.839USD 51,618,003 645.85
2025-07-31BUY88,868545.460558.130 556.863USD 49,487,302 646.43
2025-07-30BUY88,868554.580563.590 562.689USD 50,005,048 646.97
2025-07-29BUY88,868558.150559.610 559.464USD 49,718,446 647.49
2025-07-28SELL-88,868558.630567.950 567.018USD -50,389,757 650.19 Profit of 7,390,887 on sale
2025-07-25BUY88,868563.100567.210 566.799USD 50,370,295 650.70
2025-07-24BUY88,868564.640577.730 576.421USD 51,225,380 651.22
2025-07-23BUY88,868572.390576.700 576.269USD 51,211,875 651.69
2025-07-22BUY88,868560.930563.000 562.793USD 50,014,288 652.24
2025-07-21BUY88,868545.530552.980 552.235USD 49,076,019 652.89
2025-07-18BUY88,868542.520550.890 550.053USD 48,882,111 653.57
2025-07-17BUY88,868550.000554.480 554.032USD 49,235,714 654.21
2025-07-16BUY88,868547.930558.350 557.308USD 49,526,845 654.87
2025-07-15BUY88,868547.960574.750 572.071USD 50,838,806 655.54
2025-07-14BUY88,868570.590575.130 574.676USD 51,070,307 656.07
2025-07-11BUY88,868567.740568.460 568.388USD 50,511,506 656.63
2025-07-10BUY88,868559.760566.370 565.709USD 50,273,427 657.25
2025-07-09BUY88,868552.580558.380 557.800USD 49,570,571 657.92
2025-07-08BUY88,868547.750559.460 558.289USD 49,614,029 658.63
2025-07-07BUY88,868538.110547.590 546.642USD 48,578,983 659.41
2025-07-04BUY88,868 547.360* 660.15
2025-07-03BUY88,868547.360555.000 554.236USD 49,253,845 660.89
2025-07-02BUY88,868547.740551.500 551.124USD 48,977,288 661.64
2025-06-30BUY88,868525.000526.080 525.972USD 46,742,081 662.55
2025-06-27BUY88,868521.000531.210 530.189USD 47,116,838 663.50
2025-06-26BUY88,868521.000524.520 524.168USD 46,581,763 664.46
2025-06-25BUY88,868520.290525.630 525.096USD 46,664,232 665.44
2025-06-24BUY88,868522.270527.450 526.932USD 46,827,394 666.42
2025-06-23BUY88,868511.920516.180 515.754USD 45,834,026 667.49
2025-06-20BUY88,868509.720521.310 520.151USD 46,224,779 668.58
2025-06-19BUY88,868 513.580* 669.67
2025-06-18BUY88,868513.580519.170 518.611USD 46,087,921 670.77
2025-06-17BUY88,868508.860523.010 521.595USD 46,353,105 671.92
2025-06-16BUY88,868522.680538.200 536.648USD 47,690,835 672.98
2025-06-13BUY88,868529.240529.550 529.519USD 47,057,293 674.02
2025-06-12BUY88,868521.840525.220 524.882USD 46,645,211 675.12
2025-06-11BUY88,868518.600528.370 527.393USD 46,868,361 676.26
2025-06-10BUY88,868523.530529.990 529.344USD 47,041,742 677.38
2025-06-09BUY88,868517.600518.270 518.203USD 46,051,666 678.57
2025-06-06BUY88,868493.220499.880 499.214USD 44,364,150 679.95
2025-06-05BUY88,868483.070491.770 490.900USD 43,625,300 681.43
2025-06-04BUY88,868484.930499.900 498.403USD 44,292,077 682.92
2025-06-03BUY88,868487.860501.110 499.785USD 44,414,892 684.41
2025-06-02BUY88,868490.810502.560 501.385USD 44,557,082 685.90
2025-05-30BUY88,868490.280519.780 516.830USD 45,929,651 687.41
2025-05-29BUY88,868605.390605.730 605.696USD 53,826,991 688.05
2025-05-28BUY88,868591.850606.000 604.585USD 53,728,260 688.81
2025-05-27BUY88,868603.260608.170 607.679USD 54,003,216 689.49
2025-05-26BUY88,868 588.340* 690.30
2025-05-23BUY88,868588.340591.640 591.310USD 52,548,538 691.12
2025-05-22BUY88,868596.850605.500 604.635USD 53,732,703 691.89
2025-05-21SELL-88,868604.620617.520 616.230USD -54,763,129 695.85 Profit of 7,075,304 on sale
2025-04-29BUY72,394568.910579.980 578.873USD 41,906,930 696.89
2025-04-28BUY139,452610.860614.830 614.433USD 85,683,913 697.61
2025-04-25BUY139,452602.640602.790 602.775USD 84,058,177 698.41
2025-04-24BUY144,856599.760601.280 601.128USD 87,077,002 699.25
2025-04-23BUY150,260587.850603.770 602.178USD 90,483,269 700.20
2025-04-22BUY150,260585.490587.100 586.939USD 88,193,451 701.19
2025-04-21BUY150,260561.490570.350 569.464USD 85,567,657 702.40
2025-04-18BUY150,260 563.160* 703.62
2025-04-17BUY150,260563.160564.210 564.105USD 84,762,420 704.87
2025-04-16BUY150,260549.280561.830 560.575USD 84,232,002 706.26
2025-04-15BUY150,260557.910575.200 573.471USD 86,169,754 707.59
2025-04-14BUY150,260571.060574.720 574.354USD 86,302,428 708.83
2025-04-11BUY150,260554.180555.530 555.395USD 83,453,657 710.25
2025-04-10BUY150,260546.390571.990 569.430USD 85,562,551 711.77
2025-04-09BUY150,260576.720580.730 580.329USD 87,200,232 713.03
2025-04-08BUY150,260556.810586.030 583.108USD 87,617,812 714.51
2025-04-07BUY150,260572.780591.540 589.664USD 88,602,910 715.85
2025-04-04BUY150,260573.450612.990 609.036USD 91,513,748 717.22
2025-04-02BUY150,260625.600628.000 627.760USD 94,327,217 718.11
2025-04-01BUY150,260617.000641.240 638.816USD 95,988,491 719.10
2025-03-31BUY150,260634.230640.720 640.071USD 96,177,064 719.95
2025-03-28BUY150,260637.360642.970 642.409USD 96,528,372 720.77
2025-03-27BUY150,260635.830643.430 642.670USD 96,567,593 721.63
2025-03-26BUY67,058640.140644.000 643.614USD 43,159,468 722.46
2025-03-10BUY83,202744.830748.290 747.944USD 62,230,435 728.71
2025-03-07BUY150,260707.510729.750 727.526USD 109,318,057 728.96
2025-03-06BUY67,058698.440701.000 700.744USD 46,990,491 729.32
2025-02-26BUY29,122706.940721.410 719.963USD 20,966,762 732.14
2025-02-14BUY42,100673.600684.000 682.960USD 28,752,616 733.69
2025-02-13BUY42,100674.270677.690 677.348USD 28,516,351 734.48
2025-02-12BUY42,100663.860670.980 670.268USD 28,218,282 735.43
2025-02-11BUY42,100665.460680.790 679.257USD 28,596,719 736.39
2025-02-10BUY42,100690.360719.780 716.838USD 30,178,881 737.03
2025-02-07BUY42,100710.000731.420 729.278USD 30,702,603 737.41
2025-02-06BUY42,100722.070734.270 733.050USD 30,861,406 737.63
2025-02-05BUY42,100716.720729.250 727.997USD 30,648,674 737.93
2025-02-04BUY42,100697.050709.980 708.687USD 29,835,722 738.53
2025-02-03BUY42,100666.850673.650 672.970USD 28,332,038 739.60
2025-01-31BUY42,100672.980688.000 686.498USD 28,901,566 740.61
2025-01-30BUY42,100683.080689.620 688.966USD 29,005,468 741.50
2025-01-29BUY42,100687.270697.570 696.540USD 29,324,334 742.35
2025-01-28BUY42,100686.330690.300 689.903USD 29,044,916 743.23
2025-01-27BUY42,100684.710698.450 697.076USD 29,346,900 744.18
2025-01-24BUY42,100675.790693.840 692.035USD 29,134,674 745.30
2025-01-23BUY42,100694.640696.190 696.035USD 29,303,074 746.14
2025-01-22BUY42,100680.030699.880 697.895USD 29,381,380 747.26
2025-01-21BUY42,100687.800692.930 692.417USD 29,150,755 748.29
2025-01-20BUY42,100 681.580* 749.46
2025-01-17BUY42,100681.580707.480 704.890USD 29,675,868 750.67
2025-01-15BUY42,100703.430712.600 711.683USD 29,961,853 752.61
2025-01-14BUY42,100690.870715.980 713.469USD 30,037,044 753.78
2025-01-13BUY42,100716.900717.370 717.323USD 30,199,298 754.48
2025-01-09BUY42,100 733.590* 756.05
2025-01-08SELL-42,100733.590743.280 742.311USD -31,251,294 766.49 Profit of 1,018,141 on sale
2025-01-02BUY42,100715.190726.810 725.648USD 30,549,781 767.56
2024-12-31BUY42,100712.330713.000 712.933USD 30,014,479 768.74
2024-12-30BUY42,100702.590708.970 708.332USD 29,820,776 770.18
2024-12-27BUY42,100712.400718.990 718.331USD 30,241,735 771.46
2024-12-26BUY42,100716.680718.490 718.309USD 30,240,808 772.71
2024-12-20BUY42,100701.850717.610 716.034USD 30,145,031 777.58
2024-12-19BUY42,100708.250714.050 713.470USD 30,037,087 779.32
2024-12-18BUY42,100714.620745.000 741.962USD 31,236,600 780.97
2024-12-17BUY42,100740.010744.800 744.321USD 31,335,914 782.05
2024-12-11BUY42,100773.000781.320 780.488USD 32,858,545 784.20
2024-12-10BUY42,100778.500791.490 790.191USD 33,267,041 784.37
2024-12-09BUY42,100788.000800.990 799.691USD 33,666,991 784.26
2024-12-06BUY42,100778.000778.120 778.108USD 32,758,347 784.46
2024-12-05BUY42,100767.900768.020 768.008USD 32,333,138 784.99
2024-12-04BUY42,100754.260756.130 755.943USD 31,825,201 786.02
2024-12-03BUY42,100749.570770.000 767.957USD 32,330,990 787.27
2024-12-02BUY42,100762.340763.890 763.735USD 32,153,244 788.16
2024-11-29BUY42,100750.220754.510 754.081USD 31,746,810 789.57
2024-11-28BUY42,100 754.870* 790.90
2024-11-25BUY42,100749.510757.860 757.025USD 31,870,752 796.07
2024-11-22BUY42,100738.000751.400 750.060USD 31,577,527 798.71
2024-11-21BUY42,100744.500757.560 756.254USD 31,838,293 801.29
2024-11-20BUY42,100743.350750.690 749.956USD 31,573,148 804.19
2024-11-19BUY42,100744.600758.600 757.200USD 31,878,119 807.32
2024-11-12BUY42,100821.000831.000 830.000USD 34,943,000 809.18
2024-11-11SELL-42,100825.680834.420 833.546USD -35,092,286 808.15 Loss of -1,069,013 on sale
2024-11-08BUY42,100828.420830.730 830.499USD 34,964,007 806.80
2024-11-05BUY42,100829.430836.630 835.910USD 35,191,811 802.62
2024-11-01SELL-42,100843.600862.000 860.160USD -36,212,736 796.44 Loss of -2,682,443 on sale
2024-10-29BUY42,100927.330932.380 931.875USD 39,231,938 741.65
2024-10-28BUY42,100928.610943.270 941.804USD 39,649,949 710.49
2024-10-23BUY42,100941.390959.600 957.779USD 40,322,495 482.37
2024-10-18SELL-42,100990.6801,002.690 1,001.489USD -42,162,687 0.00 Loss of -42,162,687 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19208,6591,635312,81266.7%
2025-09-18236,4853,679387,51961.0%
2025-09-17229,191716370,89561.8%
2025-09-16173,632584271,02064.1%
2025-09-15204,491251334,49661.1%
2025-09-12117,50433222,76052.7%
2025-09-11125,4783,137286,51643.8%
2025-09-10195,068481339,88557.4%
2025-09-09129,168994274,52047.1%
2025-09-08250,895396527,06247.6%
2025-09-05170,149290289,56658.8%
2025-09-04188,2272,103360,61952.2%
2025-09-03185,679344438,11142.4%
2025-09-02191,954138476,28840.3%
2025-08-29133,226685236,72656.3%
2025-08-28116,5602,177256,67545.4%
2025-08-27113,719465243,83646.6%
2025-08-26210,376450400,19952.6%
2025-08-25149,13068363,37741.0%
2025-08-22211,8223,244701,77030.2%
2025-08-21257,4923,416446,43957.7%
2025-08-20327,738572559,13358.6%
2025-08-19118,4722,191324,31136.5%
2025-08-18146,282388277,90952.6%
2025-08-15209,9233,375441,75247.5%
2025-08-14157,5693,623429,32736.7%
2025-08-13111,342233362,78630.7%
2025-08-12117,647171310,77537.9%
2025-08-11129,5132,676284,75745.5%
2025-08-08128,5591,038431,84129.8%
2025-08-07166,6481,560352,87747.2%
2025-08-06176,311624397,08944.4%
2025-08-05154,257115353,74443.6%
2025-08-04200,7581,913409,89749.0%
2025-08-01349,7753,745728,72048.0%
2025-07-31222,350476549,34440.5%
2025-07-30106,8391,689231,76146.1%
2025-07-29149,359276292,66751.0%
2025-07-28103,6871,380245,28742.3%
2025-07-25103,783556259,06940.1%
2025-07-24156,9742,397291,67753.8%
2025-07-23168,7341,708355,37247.5%
2025-07-22116,324617304,88038.2%
2025-07-2198,482900250,10739.4%
2025-07-18183,1741,051391,90946.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.